Pyridostigmine Bromide Tablet, Extended Release
Product Images NDC 60846-559

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 60846-559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pyridostigmine Bromide Extended Release Tablets 1)

Chemical structure of pyridostigmine bromide, showing the molecular arrangement including a pyridine ring bonded to an ester and a trimethylamine group, with a bromide ion indicated.*

FDA Label Image

Figure 1 (Pyridostigmine Bromide Extended Release Tablets 2)

A line graph depicting mean concentration (ng/mL) over time (hours) for four conditions: Fasting, LFLC, MFMC, and HFHC. Each condition is represented by distinct markers on lines showing fluctuating concentration levels peaking between 2 to 10 hours and declining towards zero by 36 to 42 hours.*

FDA Label Image

Bag Label (Pyridostigmine Bromide Extended Release Tablets 3)

Label for Pyridostigmine Bromide Extended-Release Tablets, 105 mg per tablet, in a package containing 10 blisters of 7 tablets. The label includes storage instructions, a section for date of opening, discard instructions after 3 months, and is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

FDA Label Image

Carton (Pyridostigmine Bromide Extended Release Tablets 4)

Packaging label for Pyridostigmine Bromide Extended-Release Tablets 105 mg, oral dosage form, supplied in a carton containing 7 tablets. The labeler is Amneal Pharmaceuticals LLC. The label includes storage instructions, lot, expiration, and serialization placeholders, along with a barcode and NDC 60846-55927.*

FDA Label Image

Blister (Pyridostigmine Bromide Extended Release Tablets 5)

Labels for Pyridostigmine Bromide extended-release tablets, 105 mg strength. Each label shows the drug name, dosage form, and strength, with manufacturer listed as Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. The label includes the NDC 60846-559-27, contains a barcode, and notes Rx only status. Multiple identical labels appear arranged on the sheet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.